| | 1809249-37-3 Basic information More.. |
| Product Name: | Remdesivir | | Synonyms: | Remdesivir;Remdesivir API;Remdesivir Powder;high purity Remdesivir;Redecivir (API);Remdesivir liquid;Remdesivir lypholized powder;remdesivir producing | | CAS: | 1809249-37-3 | | MF: | C27H35N6O8P | | MW: | 602.58 | | EINECS: | 210-629-4 | | Mol File: | 1809249-37-3.mol |  |
Use
Remdesivir is an antiviral nucleotide analogue used for therapy of severe novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) infection. Remdesivir therapy is given intravenously for 3 to 10 days and is frequently accompanied by transient, reversible mild-to-moderate elevations in serum aminotransferase levels but has been only rarely linked to instances of clinically apparent liver injury, its hepatic effects being overshadowed by the systemic effects of COVID-19.
- Remdesivir
-
- US $6800.00 / KG
- 2024-04-23
- CAS:1809249-37-3
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 10kg
- Remdesivir EP/USP/BP
-
- US $1.10 / g
- 2024-04-17
- CAS:1809249-37-3
- Min. Order: 1g
- Purity: 99.9% min
- Supply Ability: 100 tons min
- Remdesivir
-
- US $1.00 / mg
- 2024-04-15
- CAS:1809249-37-3
- Min. Order: 10mg
- Purity: 99
- Supply Ability: 100ton
|
|
1809249-37-3
Recommend Suppliers |
|